CTEV

Claritev Corporation

56
Fundamentals63/ 100
Valuation50/ 100
Upside potential72/ 100
Risk potential62/ 100

CTEV lost money over the past year, so it has no meaningful PE right now.

CTEV Fundamentals

MetricStatus
Stable
Stable
Under pressure
Weak

CTEV's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.

CTEV PE Valuation

CTEV has no meaningful PE right now: it lost money over the past year.

CTEV Forward outlook

MetricOutlook
--
Losses steady
Growth
Stable
Limited
High

Analysts expect CTEV's revenue to grow, with its earnings and profitability holding steady.

CTEV Risk to reward

ScenarioChangePrice
Upside+162%$70.51
Downside-62%$10.29

Calculated from the latest close: $26.90 on Nov 12.

CTEV's one-year upside scenario is more than twice its downside: +162% against −62%.

CTEV Earnings Per Share

Q4 2023: $-5.60Q1 2024: $-38.80Q2 2024: $-72.00Q3 2024: $-94.65Q4 2024: $-101.92Q1 2025: $-73.10Q2 2025: $-41.31Q3 2025: $-21.29Q4 2025: $-17.30Q1 2026: $-17.33Q2 2026: $-17.01Q3 2026: $-16.42
Q4 2023: $-5.60Q1 2024: $-38.80Q2 2024: $-72.00Q3 2024: $-94.65Q4 2024: $-101.92Q1 2025: $-73.10Q2 2025: $-41.31Q3 2025: $-21.29Q4 2025: $-17.30Q1 2026: $-17.33Q2 2026: $-17.01Q3 2026: $-16.42
QuarterTTM EPSYoY
Q3 2026-$16.42+$4.87
Q2 2026-$17.01+$24.30
Q1 2026-$17.33+$55.77
Q4 2025-$17.30+$84.62
Q3 2025-$21.29+$73.36
Q2 2025-$41.31+$30.69
Q1 2025-$73.10-$34.30
Q4 2024-$101.92-$96.32

CTEV is still losing money, but far less than before: $16.42 per share over the past year, against $101.92 at its worst in late 2024.

CTEV Quarterly Revenue

Q4 2023: $244MQ1 2024: $235MQ2 2024: $233MQ3 2024: $230MQ4 2024: $232MQ1 2025: $231MQ2 2025: $242MQ3 2025: $246MQ4 2025: $247MQ1 2026: $245MQ2 2026: $257MQ3 2026: $268M
Q4 2023: $244MQ1 2024: $235MQ2 2024: $233MQ3 2024: $230MQ4 2024: $232MQ1 2025: $231MQ2 2025: $242MQ3 2025: $246MQ4 2025: $247MQ1 2026: $245MQ2 2026: $257MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$268.3M+9.1%
Q2 2026$257.5M+6.6%
Q1 2026$244.7M+5.8%
Q4 2025$246.6M+6.2%
Q3 2025$246M+6.7%
Q2 2025$241.6M+3.5%
Q1 2025$231.3M-1.4%
Q4 2024$232.1M-4.9%

CTEV's revenue has grown year over year for six quarters in a row: $268M last quarter, up 9.1% from the same quarter a year ago.

CTEV Free Cash Flow

Q4 2023: −$4MQ1 2024: $19MQ2 2024: −$7MQ3 2024: $41MQ4 2024: −$64MQ1 2025: −$69MQ2 2025: $37MQ3 2025: −$16MQ4 2025: $36MQ1 2026: −$93MQ2 2026: $55MQ3 2026: −$26M
Q4 2023: −$4MQ1 2024: $19MQ2 2024: −$7MQ3 2024: $41MQ4 2024: −$64MQ1 2025: −$69MQ2 2025: $37MQ3 2025: −$16MQ4 2025: $36MQ1 2026: −$93MQ2 2026: $55MQ3 2026: −$26M
QuarterFree cash flowYoY
Q3 2026-$26.2M-$9.9M
Q2 2026$54.6M+49%
Q1 2026-$92.5M-$23.6M
Q4 2025$36.4M+$100.2M
Q3 2025-$16.3M-140%
Q2 2025$36.6M+$43.6M
Q1 2025-$68.9M-459%
Q4 2024-$63.8M-$60.2M

CTEV's free cash flow was −$28M over the past year, against −$113M the year before.

CTEV Total Shares

Q4 2023: 16MQ1 2024: 16MQ2 2024: 16MQ3 2024: 16MQ4 2024: 16MQ1 2025: 16MQ2 2025: 16MQ3 2025: 16MQ4 2025: 16MQ1 2026: 17MQ2 2026: 17MQ3 2026: 17M
Q4 2023: 16MQ1 2024: 16MQ2 2024: 16MQ3 2024: 16MQ4 2024: 16MQ1 2025: 16MQ2 2025: 16MQ3 2025: 16MQ4 2025: 16MQ1 2026: 17MQ2 2026: 17MQ3 2026: 17M
PeriodChange %Net change
Quarterly+0.1%+10.3K shares
1 year+3%+495K shares
3 years+5%+814K shares
5 years+4%+653K shares
Available history+562%+14.4M shares

CTEV has 17M diluted shares, up 3% from a year ago.

CTEV Net Leverage

Q4 2023: 7.7xQ1 2024: 85.5xQ2 2025: 52.3xQ3 2025: 10.3xQ4 2025: 9.6xQ1 2026: 9.7xQ2 2026: 9.6xQ3 2026: 9.4x
Q4 2023: 7.7xQ1 2024: 85.5xQ2 2025: 52.3xQ3 2025: 10.3xQ4 2025: 9.6xQ1 2026: 9.7xQ2 2026: 9.6xQ3 2026: 9.4x
QuarterNet LeverageStatus
Q3 20269.4xHigh
Q2 20269.6xHigh
Q1 20269.7xHigh
Q4 20259.6xHigh
Q3 202510.3xHigh
Q2 202552.3xHigh
Q1 202485.5xHigh
Q4 20237.7xHigh

CTEV's net debt is about 9.4 years of its operating earnings (EBITDA), down from 10 years a year ago.

CTEV Weekly Momentum

MetricValueStatus
RSI48.9Neutral
Stochastic21.6Neutral

CTEV's weekly RSI is 49 (neutral) and its Stochastic is 22 (neutral).

CTEV PE vs Healthcare Sector

MetricCTEVSector medianRelative
PEN/A26x—

CTEV has no meaningful PE right now: it lost money over the past year.

CTEV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$23.913% above
20 week MA$29.17.6% below
50 week MA$26.90.1% below
100 week MA$32.317% below
200 week MA$36.326% below

CTEV has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 26% below its 200-week average.

CTEV Yearly ROI

YearStart priceEnd priceROI
2020$388.8$357.2-8.1%
2021$357.2$176.8-51%
2022$176.8$47.6-73%
2023$47.6$57.6+21%
2024$57.6$17.5-70%
2025$17.5$42.0+140%
2026 YTD$42.0$26.9-36%

CTEV's yearly returns have swung widely, from +140% in 2025 to −73% in 2022. It's down 36% so far in 2026.

Give your agent the market.

Get API key